breakthroughs in Recombinant Human Serum Albumin for Biopharmaceutical Applications
Recombinant human serum albumin (OsrHSA) has emerged as a major innovation in the sector of biopharmaceuticals, featuring promising advancements across various clinical and industrial programs. With its structural similarity to naturally derived human serum albumin, OsrHSA presents a safer, more trusted alternate for therapeutic use, significantly